Literature DB >> 15184109

Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice.

Suzanne A Brody1, Mark A Geyer.   

Abstract

Sensorimotor gating, measured by prepulse inhibition (PPI), is a fundamental form of information processing that is deficient in schizophrenia patients and mice lacking the gene for metabotropic glutamate receptor 5 (mGluR5). Both breeding strategies and mothering behaviors are capable of influencing the behavioral phenotype of knockout (KO) mice. Previous studies found a PPI deficit and increased startle magnitudes in mGluR5 KO mice derived from homozygous matings. Here we compared the PPI of mGluR5 wildtype (WT) and KO mice derived from heterozygous matings to that seen in mice derived from homozygous matings. Possible influences of postnatal mothering behaviors were examined using two different methods of cross-fostering. The potential developmental nature of the PPI deficit of the mGluR5 KO mice was also addressed via acute administration of the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) to C57BL/6J mice. The mGluR5 KO mice exhibited reduced PPI independently of breeding strategy or postnatal mothering behavior. Startle magnitude, however, varied with breeding strategy. The PPI deficit seen in the mGluR5 KO mice is not mimicked by acute administration of an mGluR5 antagonist, and is therefore most likely due to compensatory alterations in neuronal circuitry occurring during development independent of maternal behaviors in the postnatal environment. Copyright 2004 FP Graham Publishing Co.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184109     DOI: 10.1007/bf03033300

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  91 in total

1.  Epigenetic sources of behavioral differences in mice.

Authors:  Darlene D Francis; Kathleen Szegda; Gregory Campbell; W David Martin; Thomas R Insel
Journal:  Nat Neurosci       Date:  2003-05       Impact factor: 24.884

Review 2.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

3.  Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.

Authors:  Y M Lu; Z Jia; C Janus; J T Henderson; R Gerlai; J M Wojtowicz; J C Roder
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

Review 4.  N-methyl-D-aspartic acid receptor structure and function.

Authors:  C J McBain; M L Mayer
Journal:  Physiol Rev       Date:  1994-07       Impact factor: 37.312

5.  Metabotropic glutamate receptors are differentially regulated during development.

Authors:  M V Catania; G B Landwehrmeyer; C M Testa; D G Standaert; J B Penney; A B Young
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

6.  Dissociation between startle and prepulse inhibition in rats exposed to gamma radiation at day 15 of embryogeny.

Authors:  M Mintz; G Yovel; A Gigi; M S Myslobodsky
Journal:  Brain Res Bull       Date:  1998       Impact factor: 4.077

Review 7.  Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders?

Authors:  Hans H Schiffer
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

8.  Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder.

Authors:  K S Cadenhead; M A Geyer; D L Braff
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112

9.  Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: linkage disequilibrium mapping using SNPs evenly distributed across the gene region.

Authors:  Chieko Makino; Yo Fujii; Rumiko Kikuta; Naotsugu Hirata; Ayako Tani; Atsushi Shibata; Hideaki Ninomiya; Nobutada Tashiro; Hiroki Shibata; Yasuyuki Fukumaki
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-01-01       Impact factor: 3.568

10.  Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

Authors:  R S Mansbach; M A Geyer
Journal:  Neuropsychopharmacology       Date:  1989-12       Impact factor: 7.853

View more
  14 in total

Review 1.  Gene-environment interplay in schizopsychotic disorders.

Authors:  Tomas Palomo; Trevor Archer; Richard M Kostrzewa; Rrichard J Beninger
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 2.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

3.  Environmental Enrichment Ameliorates Behavioral Impairments Modeling Schizophrenia in Mice Lacking Metabotropic Glutamate Receptor 5.

Authors:  Emma L Burrows; Caitlin E McOmish; Laetitia S Buret; Maarten Van den Buuse; Anthony J Hannan
Journal:  Neuropsychopharmacology       Date:  2015-02-10       Impact factor: 7.853

4.  Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.

Authors:  Alexia M Thomas; Nghiem Bui; Deanna Graham; Jennifer R Perkins; Lisa A Yuva-Paylor; Richard Paylor
Journal:  Behav Brain Res       Date:  2011-05-06       Impact factor: 3.332

Review 5.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 6.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

Review 7.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

8.  Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment.

Authors:  David Hessl; Elizabeth Berry-Kravis; Lisa Cordeiro; Jennifer Yuhas; Edward M Ornitz; Aaron Campbell; Elizabeth Chruscinski; Crystal Hervey; James M Long; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

Review 9.  Animal models and measures of perceptual processing in schizophrenia.

Authors:  Steven J Siegel; John C Talpos; Mark A Geyer
Journal:  Neurosci Biobehav Rev       Date:  2013-07-15       Impact factor: 8.989

10.  Prepulse inhibition and genetic mouse models of schizophrenia.

Authors:  Susan B Powell; Xianjin Zhou; Mark A Geyer
Journal:  Behav Brain Res       Date:  2009-05-04       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.